1. Neither vaginal nor buccal administration of 800 μg misoprostol alters mucosal and systemic immune activation or the cervicovaginal microbiome: a pilot study. (1st November 2016) Authors: Kalams, Spyros A.; Rogers, Lisa M.; Smith, Rita M.; Barnett, Louise; Crumbo, Katie; Sumner, Shonda; Prashad, Naomi; Rybczyk, Kyle; Milne, Ginger; Dowd, Scot E.; Chong, Erica; Winikoff, Beverly; Aronoff, David M. Journal: European journal of contraception & reproductive health care Issue: Volume 21:Number 6(2016:Dec.) Page Start: 436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗